Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia
المؤلف
المصدر
Schizophrenia Research and Treatment
العدد
المجلد 2011، العدد 2011 (31 ديسمبر/كانون الأول 2011)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-10-27
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Ziprasidone (ZIP) shows a low propensity for metabolic side effects but can prolong QTc time.
It is unclear how these features translate into clinical reality.
Charts of inpatients with schizophrenia and switched from (ZIP−,n=27) or to ZIP (ZIP+,n=24) were reviewed.
Clinical data including documented switch reasons were anonymously analyzed.
Comorbidity, body mass index (BMI) at admission, illness severity, side effects, illness duration, and length of stay were comparable in both groups.
About 2/3 of ZIP+ were women (1/3 of ZIP−,P=0.035); ZIP+ patients were younger (P=0.017), had higher BMI values (P=0.042), and received higher chlorpromazine equivalents before switch (P=0.004) whereas ZIP doses were comparable (136 versus 141 mg/d).
More patients in ZIP− versus ZIP+ were switched because of previous weight gain (P=0.006) and depression (P=0.085) whereas single reasons for ZIP− versus ZIP+ were mainly persisting positive symptoms (P=0.089) and patients' choice (P=0.10).
The results of the naturalistic study corroborate controlled trials.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Müller, Matthias J.. 2011. Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia. Schizophrenia Research and Treatment،Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-462995
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Müller, Matthias J.. Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia. Schizophrenia Research and Treatment No. 2011 (2011), pp.1-7.
https://search.emarefa.net/detail/BIM-462995
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Müller, Matthias J.. Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia. Schizophrenia Research and Treatment. 2011. Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-462995
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-462995
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر